Collage photo of Istvan Petak and Roupen Odabashian
Mar 28, 2025, 16:39
Istvan Petak breaks down Genomate Health’s impact on cancer care with Roupen Odabashian on OncoDaily Dialogues
Genomate Health shared a post on LinkedIn:
“In a minute, Dr. Istvan Petak, Founder and CEO of Genomate Health, breaks down exactly what Genomate does, and why it matters, on OncoDaily Dialogues with Roupen Odabashian, MD, FRCPC, ABIM.
Discover how Genomate is transforming cancer care by making precision oncology accessible, scalable, and clinically actionable.
Watch the full conversation here.”
Proceed to the video attached to the post.
More posts featuring Genomate Health.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 17:19
Mar 30, 2025, 16:56
Mar 30, 2025, 16:44
Mar 30, 2025, 16:43